Director, Global Value and Health Economics and Outcomes Research (HEOR)
Контакты
212 000 - 318 000$
Формат работы
remote (только USA)
Тип работы
fulltime
Грейд
director
Английский
b2
Страна
US
market accessoncologyeconomic modelingheorhealth economicsreal world evidenceoutcomes researchrare diseasehealth technology assessment
Вакансия из Hirify Global, списка международных tech-компаний Для мэтча и отклика нужен Plus
Пожаловаться
Зарплата и рынок
развернуть
$212к-318к/год
$220к$250кмедиана$280к
По похожим ролям (38) ~ $250к/год
87
Хорошая вакансия
развернуть
Это четко описанная руководящая роль в известной биофармацевтической компании с большой ответственностью за глобальную доказательную стратегию и доступ на рынок США; ограничение по месту проживания в США сужает круг тех, кому она доступна.
Только для США
Широкая зона ответственности
Известная биофарма
Мэтч & Сопровод
Для мэтча с этой вакансией нужен Plus
Подключить Plus
Описание вакансии
Текст:
Hirify AI/Оригинал
TL;DR
Director, Global Value and Health Economics and Outcomes Research (HEOR): Leading global and US payer evidence strategy for marketed oncology assets, including lifecycle management, label expansions, value defense, and post-launch evidence generation with an accent on advanced health economic modeling, real-world evidence, and HTA strategy. Focus on building economic models, AMCP and global value dossiers, rare disease registries, comparative effectiveness studies, and payer-facing evidence for complex market access decisions.
Base pay: $212,000–$318,000 per year for US-based candidates; additional discretionary bonus, incentive compensation, equity, and benefits may apply.
Company
hirify.global is a global biopharmaceutical company developing medicines for serious diseases, with a portfolio spanning sleep disorders, epilepsy, oncology, and neuroscience.
What you will do
Lead global and US payer evidence strategy for marketed oncology assets across label expansions, new formulations, line extensions, competitive shifts, and post-launch lifecycle management.
Design and execute evidence programs including comparative effectiveness studies, pragmatic trials, patient registries, real-world observational research, systematic reviews, meta-analyses, Global Value Dossiers, and US AMCP dossiers.
Direct US HEOR activities, partnering with Market Access, Pricing and Contracting, Medical Affairs, and Payer Field Teams on payer tools, budget impact models, value summaries, and reactive scientific communications.
Develop and adapt cost-effectiveness, cost-utility, budget impact, cost-offset, Markov, partitioned survival, microsimulation, and dynamic population models using clinical and real-world data.
Collaborate with EU/INT HEOR teams on HTA reassessments, renewals, conditional reimbursement, pricing negotiations, and global evidence packages.
Lead cross-functional governance, publications, vendors, budgets, external partners, and technical mentorship across evidence and value generation activities.
Requirements
Master’s degree in Health Economics, Outcomes Research, Pharmacoeconomics, Public Health, or a closely related quantitative field, or a PhD.
7–10 years of experience in HEOR, Global Value, or Health Economics within biopharma or a top-tier HEOR consulting firm.
Extensive experience developing post-marketing HEOR strategies, lifecycle evidence roadmaps, label-expansion evidence, and value-defense strategies for marketed pharmaceutical products.
Comprehensive knowledge of US managed care, commercial payers, Medicare Part D/Advantage, Medicaid, PBMs, integrated delivery networks, and global HTA environments including EU JCA, NICE, G-BA, and CADTH.
Proven expertise building, adapting, and validating economic models using mature clinical trial and real-world data, including Markov, partitioned survival, microsimulation, and dynamic budget impact models.
Experience with US payer field enablement, AMCP dossiers, US budget impact models, customer-facing economic tools, and compliance with FDAMA Section 114 and the 21st Century Cures Act.
Knowledge of rare disease evidence challenges, including registries, natural history benchmarks, long-term follow-up, surrogate endpoint validation, and specialized reimbursement mechanisms.
Working knowledge of major healthcare databases such as IQVIA, Optum, MarketScan, Medicare SAF, disease-specific registries, and electronic health records, plus advanced epidemiological methods.
Experience leading at least two assets as a US HEOR lead or country-level HTA lead, or equivalent global HEOR product leadership experience.
Nice to have
Experience with oncology assets and oncology care pathways.
Experience with post-marketing RWE, patient registry studies, and economic evaluations in rare diseases, specialized medicine, or complex chronic conditions.
Experience collaborating with EU/INT HEOR teams on HTA reassessments, renewals, or pricing renegotiations.
Strong peer-reviewed publication record in health economics and outcomes research.
Culture & Benefits
Full-time employment in a global, patient-focused, science-driven biopharmaceutical organization.
Remote home-based work for US-based candidates.
Medical, dental, and vision insurance; 401(k) retirement savings plan; and flexible paid vacation.
Potential eligibility for annual cash bonus or incentive compensation and discretionary equity grants.
Equal opportunity and affirmative action employment practices.
Будьте осторожны
Если работодатель просит войти в их систему, используя iCloud/Google, прислать код/пароль, запустить код/ПО, не делайте этого. Это мошенники. Обязательно жмите «Пожаловаться» или пишите в поддержку. Подробнее в гайде →